© 2022 MJH Life Sciences™ and Neurology Live. All rights reserved.
Consortium of Multiple Sclerosis Centers Annual Meeting
CMSC 2021: Top Interviews and Key Takeaways
November 20, 2021
The NeurologyLive® team has compiled a roundup of our discussions with leaders in the multiple sclerosis field following the 2021 Annual Meeting of the Consortium of Multiple Sclerosis Centers (CMSC).
Therapeutic Approaches to Fatigue in Multiple Sclerosis: Anna Kratz, PhD
November 17, 2021
Discussing cognitive behavioral therapy for patients with MS, the associate professor of Physical Medicine and Rehabilitation and research nonclinical psychologist at the University of Michigan Medicine mentioned different therapeutic options that can benefit this patient population. [WATCH TIME: 3 minutes]
Anna Kratz, PhD, on Managing MS Fatigue in a Multifaceted Way
November 16, 2021
Anna Kratz, PhD, associate professor of Physical Medicine & Rehabilitation, University of Michigan Medicine, spoke to the benefits of a multifaceted approach to managing fatigue for patients with multiple sclerosis.
Strategies, Tools for Treating Fatigue in Multiple Sclerosis: Anna Kratz, PhD
November 16, 2021
The associate professor of Physical Medicine & Rehabilitation and research nonclinical psychologist at the University of Michigan Medicine discussed challenges when addressing fatigue, as well as the need to integrate digital tools for patients with MS. [WATCH TIME: 4 minutes]
A Multidisciplinary Approach to Fatigue in Multiple Sclerosis: Anna Kratz, PhD
November 14, 2021
The associate professor of Physical Medicine & Rehabilitation and nonclinical research psychologist at University of Michigan Medicine discussed the complexities of fatigue as a symptom following her presentation at CMCS 2021.
Evaluating Ocrelizumab in the CHIMES Trial: Mitzi Joi Williams, MD
November 12, 2021
The founder and CEO of Joi Wellness Group Multiple Sclerosis Center described motivations behind the evaluation of ocrelizumab (Ocrevus; Genentech) in minority populations with multiple sclerosis.
Designing an MS Clinical Trial Focused on Minority Populations: Mitzi Joi Williams, MD
November 11, 2021
Outlining the development of the CHIMES trial in multiple sclerosis, the founder and CEO of Joi Life Wellness Group Multiple Sclerosis Center spoke on tactics to get underrepresented populations involved. [WATCH TIME: 2 minutes]
Developing the CHIMES Trial for Minority Patients With MS: Mitzi Joi Williams, MD
November 10, 2021
The founder and CEO of Joi Life Wellness Group Multiple Sclerosis Center outlined the motivations behind the trial, as well as potential reasons for underrepresentation. [WATCH TIME: 2 minutes]
Takeaways for MS Clinicians on COVID-19 Vaccination: Amit Bar-OR, MD, FRCPC, FAAN, FANA
November 09, 2021
The chief of the Multiple Sclerosis Division, Perelman School of Medicine at the University of Pennsylvania emphasized current recommendations, which suggest patients with MS get vaccinated for COVID-19. [WATCH TIME: 3 minutes]
Quality of Life Improvements in MS Following Wellness Program: Brian Hutchinson, PT, MSCS
November 08, 2021
The director of the Multiple Sclerosis Achievement Center in Sacramento discussed 3-year data from an assessment of the program, outlining key findings and future research efforts. [WATCH TIME: 6 minutes]